Navigation Links
NeurogesX Reports First Quarter 2008 Results
Date:5/15/2008

Highlights:

- IND for liquid formulation, NGX-1998, expected to be opened and commencement of clinical development expected in second quarter of 2008 - NDA submission for dermal patch, NGX-4010, in PHN expected in second half

of 2008

- NGX-4010 MAA under EMEA review for peripheral neuropathic pain

SAN MATEO, Calif., May 15 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today reported results for the first quarter of 2008.

Anthony DiTonno, President and CEO, commented, "We are focused on achieving our overall goal of receiving marketing approval for our lead product candidate, NGX-4010 in the United States and Europe. Following our recent meeting with the U.S. Food and Drug Administration (FDA), we believe that we are on track to file a new drug application (NDA) later this year for the postherpetic neuralgia (PHN) indication. Our marketing authorization application (MAA) was accepted by the European Medicines Agency (EMEA) in September of last year under the centralized procedure. We have been granted an extension for our response to the Day 120 questions in order to include additional clinical data and plan to submit our response in the third quarter of 2008."

Mr. DiTonno continued, "During the second quarter of 2008, we plan to open an investigational new drug (IND) application for our second product candidate, NGX-1998, a liquid formulation of capsaicin, the same active ingredient in our lead product candidate, NGX-4010. We are evaluating our clinical program for NGX-1998 in a range of neuropathic pain conditions."

F
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. NeurogesX to Report First Quarter 2008 Financial Results
2. NeurogesX to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference
3. NeurogesX to Report Fourth Quarter and Year-End 2007 Financial Results
4. NeurogesX to Present at Roth 2008 OC Growth Stock Conference
5. NeurogesX to Present at the 10th Annual BIO CEO & Investor Conference
6. NeurogesX Closes $25 Million Private Placement
7. NeurogesX, Inc. Announces $25 Million Private Placement
8. NeurogesX to Present at Lazard Capital Markets Healthcare Conference
9. NeurogesX to Present at CIBC World Markets 18th Annual Healthcare Conference and Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
10. NeurogesX Expands Senior Management Team
11. NeurogesX to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Wash. , Dec. 24, 2014   BioLife ... leading developer, manufacturer and marketer of proprietary clinical grade ... media and precision thermal shipping products for ... that it will hold its 2015 Annual Meeting of ... Because the expected date for the Annual Meeting ...
(Date:12/24/2014)... 23, 2014 On Friday, December ... 83, the Omnibus and Continuing Resolution Appropriations Act ... hydrocephalus a condition eligible to receive funding through ... by the Department of Defense (DoD). The Hydrocephalus ... on Capitol Hill, is celebrating this victory for ...
(Date:12/24/2014)... December 23, 2014 Pipette.com announces their ... Twitter followers can submit their #HolidayInTheLab pictures for a ... lab mates. , For those struggling to think of ... Pipette.com Holiday in the Lab Contest provides the ideal ... followers to send pictures of their chemistree, holiday ...
(Date:12/24/2014)... , Dec. 23, 2014  Rock Creek Pharmaceuticals, ... it has filed a Clinical Trial Application (CTA) with ... products Regulatory Agency (MHRA) seeking regulatory approval to initiate ... molecule, Anatabine Citrate. Contingent on the Company ... a Phase I trial to assess the safety, tolerability ...
Breaking Biology Technology:BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... that do not specialize in software, but incorporate software-based ... more often than not, overlook the importance of protecting ... feature or the most prevalent feature of the product, ... and should be protected. , ,For example, many ...
... MADISON Health statistics are often broken down into categories ... meaningless concept that has no basis in biology or genetics. ... at a symposium titled Race, Genetics & Disease at Grainger ... Holtz Center for Science and Technology Studies sponsored the ...
... compete for $22,000 in awards this Friday as part ... Plan Competition . Fourteen teams of aspiring student entrepreneurs, ... their plans for technology-based businesses to a panel of ... UW System, this competition is the only activity on ...
Cached Biology Technology:Beyond the screws and gears: Protecting your products by protecting your software 2Symposium examines the effect of race on genetics and disease 2Students compete for $22,000 in Tech Business Plan Competition 2Students compete for $22,000 in Tech Business Plan Competition 3
(Date:12/10/2014)... DIEGO , Dec. 9, 2014 CIE ... collaboration catalyst that provides the connective tissue that enhances ... enabling them to easily share client-level information; earned a ... to expand to organizations serving seniors aging in community ... Diego" partner on December 11 th 4-6p. ...
(Date:12/10/2014)... 2014     ...   Jifflenow, a leading ... for business-to-business (B2B) events, today announced a partnership ... near-field communication (NFC), Bluetooth low energy (BLE), and ... , Jifflenow will integrate its meeting ...
(Date:12/5/2014)... Utah , Dec. 4, 2014  Tute Genomics, ... raised $2.3 million in Series A1 funding led by ... investors also participated in the investment round. ... the healthcare community adopts next-generation sequencing and seeks new ... said Reid Robison , MD MBA, and CEO ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3
... to investigate how lethal viruses attack differently sized populations of ... to new methods of pest control. The project, funded by ... meal moth ( Plodia interpunctella ) and a virus it ... not. Dr Steve Sait from the University of Leeds ...
... Something strange happened in 1973. Republican president Richard Nixon -- ... the land of quotas and restrictions" -- signed the Endangered ... about ecological issues -- and the rapid decline of charismatic ... to pass the law 92-0. Sounding more Thoreauvian than Thatcherite, ...
... boat owner recognises the dilemma: environmentally friendly or effective. ... a way of reconciling these two almost unattainable aims. ... biocides in the paint, it is possible to both ... the environmental impact. "It,s very easy to make ...
Cached Biology News:No safety in numbers for moths and butterflies 2Dispatches from the edge of doom 2Dispatches from the edge of doom 3Dispatches from the edge of doom 4More effective and less risky when you paint the hull of your boat 2
... Custom design, The Bioactive peptides are ... display a biological behaviour or activity which ... for pharmaceutical, diagnostic, chemical and agro-food applications. ... obtain modified peptides with superior properties for ...
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ...
... with forced convection Temperature range 5 C ... C / 212 F Patented APT.line preheating ... DS controller Timer 0 to 24 h ... a tenth of a degree Independent adjustable ...
... your microarray data using Asuragens bioinformatics ... need from consultation to extensive data ... date methods. Utilize our expertise in ... Service or from your own microarray ...
Biology Products: